Patent leaders weigh in on gene patents at BIO
The Myriad gene patent case was the highlight of the IP law sessions held at the 2010 BIO International Convention in Chicago this week
In a so-called super session featuring Eli Lilly senior vice president and general counsel Bob Armitage, USPTO director David Kappos and WIPO director-general Francis Gurry, Kappos said that the Office has spent considerable time thinking about the Myriad case.
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.